Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study

Acta Obstet Gynecol Scand. 2013 Jun;92(6):686-91. doi: 10.1111/aogs.12128. Epub 2013 Apr 9.

Abstract

Objective: To present the results of a large series of patients with ovarian hyperstimulation syndrome treated with a conservative medical approach and to compare the cost of this treatment with outpatient management with paracentesis according to published data.

Design: Retrospective case series and cost analysis study using a decision-tree model.

Setting: University hospital.

Population: 496 consecutive patients with ovarian hyperstimulation syndrome treated in our center from 1991 to 2010.

Methods: All patients were treated with a conservative medical approach: (a) conservative outpatient approach: bed rest and a low-sodium diet or (b) hospitalized patients: bed rest, low-sodium diet, 20% albumin (60 g/day) and furosemide (20 mg/8 h).

Main outcome measures: Percentage of admissions, length of hospital stay and readmissions. Total cost of each therapeutic approach.

Results: (a) Conservative outpatient approach (n = 377): all cases solved without admission. (b) Hospitalized patients with conservative medical treatment (n = 119): 2.8 days of mean hospital stay, no patient required paracentesis or admission to intensive care unit. Readmissions: Five patients (4.2%) resolved on restarting medical treatment. (c) Cost-analysis comparison: Cost of the outpatient approach with paracentesis: US$980 (range US$519-3557). Cost of conservative medical treatment: US$570 (range US$232-1640).

Conclusions: Ovarian hyperstimulation syndrome can be safely managed with a conservative medical approach, which was not found to be more expensive than outpatient management with paracentesis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albumins / administration & dosage
  • Ambulatory Care / economics
  • Bed Rest
  • Costs and Cost Analysis
  • Decision Trees
  • Diet, Sodium-Restricted
  • Diuretics / therapeutic use
  • Female
  • Furosemide / therapeutic use
  • Hematocrit
  • Hospitalization / economics
  • Humans
  • Length of Stay / statistics & numerical data
  • Ovarian Hyperstimulation Syndrome / economics*
  • Ovarian Hyperstimulation Syndrome / therapy*
  • Paracentesis / economics
  • Patient Readmission / statistics & numerical data
  • Plasma Substitutes / administration & dosage
  • Pleural Effusion / epidemiology
  • Retrospective Studies
  • Sodium / urine

Substances

  • Albumins
  • Diuretics
  • Plasma Substitutes
  • Furosemide
  • Sodium